🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-524693-42-00
Withdrawn Phase I

A study to see how RO7763505 works and how safe it is when given to healthy people and people with stable heart disease

2025-524693-42-00 · tracked via the Priya Life Science EU tracker
Sponsor
F. Hoffmann-La Roche AG
Sponsor type
Pharmaceutical company
Therapeutic area
Cardiovascular Diseases
Decision date
06/03/2026
Enrollment target
196
Sites
Netherlands

Condition studied

Stable Coronary Artery Disease (CAD)

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-524693-42-00 on CTIS ↗ ← All trials in the EU